Szczegółowych
informacji na temat substancji czynnych produkowanych przez Instytut Farmaceutyczny udziela
Dział Marketingu i Logistyki.
| Substancja |
Numer CAS |
Działanie |
| Alfacalcidol |
41294-56-8 |
Calcium metabolism regulator, vitamin D-derivative
 0.6 MB
Certificate of Suitability
0.3 MB
Certyfikat GMP |
| Anastrozole |
120511-73-1 |
Antineoplastic, non-steroidal aromatase inhibitor |
| Bicalutamide |
90357-06-5 |
Non-steroidal antiandrogen, antineoplastic, anti(prostate)cancer |
| Budesonide r |
51372-29-3 |
Glucocorticoid, antiasthmatic |
| Calcifediol |
19356-17-3 |
Calcium regulator
0.3 MB
Certyfikat GMP |
| Calcipotriol |
112828-00-9 |
Antipsoriatic, topical vitamin D3-analog
0.3 MB
Certyfikat GMP |
| Calcitriol |
32222-06-3 |
Calcium regulator
0.2 MB
Certificate of Suitability
0.3 MB
Certyfikat GMP |
| Carvedilol |
72956-09-3 |
Non-selective beta1-adrenoceptor antagonist, beta-blocker
0.3 MB
Certyfikat GMP |
| Clopidogrel |
120202-66-6 |
Platelet aggregation inhibitor
0.3 MB
Certyfikat GMP |
| Flutamide |
13311-84-7 |
Antiandrogen, antineoplastic (hormonal) |
| Genistein |
446-72-0 |
Anticancer; Protein tyrosine kinase inhibitor |
| Imatinib |
152459-95-5 |
Antitumor, tyrosine kinase inhibitor, antineoplastic |
| Latanoprost |
130209-82-4 |
Antiglaucoma, prostaglandin |
| Mizolastine |
108612-45-9 |
Antihistaminic, histamine H1-receptor antagonist |
| Moclobemide |
71320-77-9 |
Antidepressant, reversible nonhydrazide MAO-A-inhibitor, antiparkinsonian |
| Nicorandil |
65141-46-0 |
Coronary vasodilator |
| Nitrendipine |
39562-70-4 |
Antihypertensive, calcium channel blocker (calcium antagonist) |
| Olanzapine |
132539-06-1 |
Antipsychotic
0.3 MB
Certyfikat GMP |
| Pramipexole |
191217-86-9 |
Dopamine D2-agonist |
| Repaglinide |
135062-02-1 |
Antidiabetic |
| Ropinirole |
91374-20-8 |
Dopamine D2-agonist, antiparkinsonian |
| Tacalcitol |
57333-96-7 |
Antipsoriatic
0.3 MB
Certyfikat GMP |
| Tamsulosin |
106463-19-8 |
Antihypertensive, anti-BPH agent, alfa-adrenoceptor antagonist, alfa-blocker |
